Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Dova Pharmaceuticals Inc. (DOVA)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Perceptive Advisors

Joseph Edelman

3,125,851 $23,693 0.9%
2.
Broadfin Capital

Kevin Kotler

351,800 $2,667 0.35%
3.
Birchview Capital

Matthew Strobeck

40,000 $303 +34% 0.28%
4. 39,647 $301 0%
5.
Nexthera Capital

Ori Hershkovitz

0 $0 0%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$6.25 1,169 Director 61,400 2018-12-20 Filing
$6.22 28,831 Director 60,231 2018-12-19 Filing
$6.07 10,000 Officer 92,372 2018-12-20 Filing
$7.10 6,834 Large Shareholder, Director 12,882,954 2018-12-21 Filing
$6.44 121,666 Large Shareholder, Director 12,876,120 2018-12-21 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 185,000 $1,402 0.15%
2. 261,780 $1,984 0.11%
3. 61,100 $463 0.03%
4. 178,536 $1,353 0.02%
5. 20,613 $156 0.01%